Genelux (United States)

Recent papers from Genelux (United States)

1. Deep and durable response to re-challenge with platinum-based therapy in a platinum-relapsed small cell lung cancer patient following Olvi-Vec oncolytic immunotherapy: a case reportFrontiers in Oncology · 2026
2. Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean modelsBioengineered · 2019
3. Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated OncolysisMolecular Therapy — Oncolytics · 2017
4. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cellsJournal of Translational Medicine · 2016
5. Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapyMolecular Therapy — Oncolytics · 2016
6. Drug-Encoded Biomarkers for Monitoring Biological TherapiesPLoS ONE · 2015
7. Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer TherapyViruses · 2015
8. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus trapsJournal of Translational Medicine · 2015
9. Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer AgentTheranostics · 2015
10. Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell linesAnatomy & Cell Biology · 2015
11. Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancerMolecular Therapy — Oncolytics · 2015
12. Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapyMolecular Therapy — Oncolytics · 2015
13. Silk-elastin-like protein polymer matrix for intraoperative delivery of an oncolytic vaccinia virusHead & Neck · 2014
14. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvantJournal of Translational Medicine · 2014
15. The immune‐related role of BRAF in melanomaMolecular Oncology · 2014
16. Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma TherapyPLoS ONE · 2014
17. Antigen profiling analysis of vaccinia virus injected canine tumorsBioengineered · 2014
18. Inducible Gene Expression in Tumors Colonized by Modified Oncolytic Vaccinia Virus StrainsJournal of Virology · 2014
19. Isolated limb perfusion with melphalan, tumour necrosis factor‐alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcomaInternational Journal of Cancer · 2014
20. Characterization of Metastasis Formation and Virotherapy in the Human C33A Cervical Cancer ModelPLoS ONE · 2014